Cerebral microcirculation improvement

“Cerebral microcirculation improvement” refers to therapeutic interventions or drug mechanisms that enhance blood flow and oxygen/nutrient delivery in the brain’s microvascular network. Unlike canonical molecular targets, this term describes a process that underlies protection or recovery in neurological diseases, especially those with vascular pathology, such as stroke, neurodegeneration, and ischemic injury. Mechanistically, improvements may be achieved by targeting vasoactive mediators (e.g., nitric oxide, adenosine), vasodilatory signaling pathways (e.g., cGMP, PDE1 inhibition), pericyte and endothelial function, and reducing oxidative or inflammatory damage. This therapeutic goal is associated with diverse drug classes, not with a single molecular entity. The concept is useful for research and translational medicine but does not correspond to a unique, actionable biological target.

Other names

cerebral microvascular enhancementimprovement of cerebral blood flowmicrovascular flow restorationcerebral microcirculation enhancement

Vasodilation of microvessels; Relaxation of capillary pericytes; Endothelial function enhancement; Modulation of vascular smooth muscle tone; Reduction of oxidative stress; Inhibition of vasoconstrictive signaling (adrenergic/endothelin pathways); Stimulation of cGMP signaling path (PDE1 inhibition)